Vaccine Data for Kids Under 5 Are Coming ‘Before the End of the Year’
Editor’s Note: This article is part of our coverage of The Atlantic Festival. Learn more and watch festival sessions here. The vaccine timeline for young kids is looking a little more solid. This morning, Pfizer submitted data to the FDA showing that its COVID-19 vaccine is effective and safe for children ages 5 to 11. And this afternoon, the company’s CEO, Albert Bourla, said that trial results for even younger kids, aged 2 to 4, will be available in a couple months’ time.





























